Hexa3 Patchs Patchs CBD Muscles & Articulations 12x45mg HexaFLEX® Hexa3
Hexa3 Patchs Patchs CBD HexaFLEX, Muscles et Articulations
Hexa3 Patchs Patchs CBD Muscles & Articulations 12x45mg HexaFLEX® Hexa3
Hexa3 Patchs Patchs CBD HexaFLEX, Muscles et Articulations

Hexa3 HexaFLEX® CBD Patches 12x45mg

Hexa3 HexaFLEX patches dosed at 45 mg of CBD, released gently for up to 36 hours. At 7.5 x 5.8 cm, they sit precisely on the area of your choice and stay put during your workouts, in packs of 2 or 5 x 12.
Regular price 36,90 € Sale price instead of 39,80 €

Availability: In stock – Ships within 24h

1,54 €/item
Tax included. Shipping calculated at checkout.
En Stock !
Livré en France sous 2 à 3 jours
Vous n'êtes pas en France ?

Summary

HexaFLEX CBD Patches, Packs of 2 or 5 x 12 Patches

  • Precise targeting of the desired areas
  • Packs of 2 x 12 Patches or 5 x 12 Patches
  • 45mg of CBD per patch
  • CBD release for up to 36h
  • Dimensions: 7.5cm x 5.8cm

See all products:

Details

HexaFLEX CBD Patches 45mg

The patch contains 45mg of CBD, released gently over 36 hours. It stays in place during your sports sessions and even during the shower afterwards. Our CBD patches are small (7.5cm x 5.8cm) and discreet.

  • Made in France
  • Shelf life: 18 months

Using the patch

Stick your patch on clean, dry skin, in the desired spot. It can stay in place for up to 36h, then be replaced. However, take care not to use more than 2 patches at the same time.

Certification
Product made in the EU, then certified by an independent, GMP-approved laboratory. The product's certificate of analysis can be found among the photos on this page.

Composition

HexaFLEX CBD Patches 45mg

  • Backing sheet
  • 45mg of CBD per patch

Similar products

Discover the other HexaFLEX products:

Sources and references (4)

Official and scientific sources on the regulation, safety, composition and quality of this type of product. They are provided for information and are not health claims.

  1. Parlement européen ; Conseil de l'UE (2009). Règlement (CE) n° 1223/2009 du Parlement européen et du Conseil du 30 novembre 2009 relatif aux produits cosmétiques (refonte). Journal officiel de l'Union européenne (EUR-Lex). View the source
  2. Scientific Committee on Consumer Safety (SCCS) (2026). SCCS — Scientific Advice on Cannabidiol (CBD) (CAS/EC No. 13956-29-1/689-176-3) used in cosmetic products (SCCS/1685/25). Commission européenne — DG SANTE, Comité scientifique pour la sécurité des consommateurs. View the source
  3. Cour de justice de l'Union européenne (2020). Arrêt dans l'affaire C-663/18 B S et C A (Kanavape) — Communiqué de presse n° 141/20 : un État membre ne peut interdire la commercialisation du CBD légalement produit dans un autre État membre. CJUE — Communiqué de presse n° 141/20 (19 novembre 2020). View the source
  4. République française (2022). Code de la santé publique — Article R5132-86 (version en vigueur depuis le 1er mars 2022, décret n° 2022-194 du 17 février 2022). Légifrance. View the source

Recently viewed